It is unimaginable, but it actually took place... a surgical operation from China to Brazil, a distance of 14,000 kilometres! China is penetrating deep into the heart of the Latin American healthcare infrastructure system, causing intense irritation in the West with its record-breaking acceptance and technological advancement. The president of Brazil, Luiz Inacio Lula da Silva, made a move of immense symbolism, publicly praising cutting-edge Chinese technology at the exact same time that bilateral trade relations between the two countries are shattering every historical record, reaching 188 billion dollars and consolidating China as the country's absolute and "best partner." "It is incredible to see firsthand how innovation can expand access, save lives, and further strengthen Brazil's Unified Health System," emphasized Luiz Inacio Lula da Silva.
The Chinese miracle executing surgeries from 14,000 kilometres away
The Brazilian president's statement was made immediately after his participation in a simulation of a remote surgical procedure utilizing the Chinese Toumai MT-1000 robot, which was controlled from a distance of 14,000 kilometres. This specific system, developed by the company Shanghai MicroPort MedBot, shattered the global record for the longest distance ever covered for a remote robotic surgery. According to a company spokesperson, Toumai is currently the only commercial robotic surgery system in the world capable of supporting all major medical departments and the most intricate operations. The robot features:
-
A 3D naked-eye imaging platform with 10x optical magnification, offering the surgeon a high-definition view of the surgical field.
-
A robotic arm with seven degrees of freedom, which completely filters out the natural tremors of the physician's hands.
-
Articulated instruments offering flexibility and stability that surpass the capabilities of the human hand within narrow body cavities.
The incursion into the US and approval in 13 countries
This Chinese medical miracle has already secured regulatory approval in 13 countries, including China, Brazil, India, and Thailand. The most striking element, however, is that it has received an Investigational Device Exemption from the US FDA (FDA-IDE). This renders it the only system in the world licensed to conduct clinical human surgical research inside the United States, transitioning smoothly into the stage of real-world commercial application. The robot executes with absolute success some of the most hazardous operations, including pancreatoduodenectomy (one of the most challenging abdominal surgeries), radical prostatectomy, as well as remote atrial septal defect corrections combined with tricuspid valvuloplasty in the heart.
Upheaval in Brazilian hospitals and 5G technology
Before integrating into Brazil's public healthcare system, the Chinese company conducted a series of exhaustive trials in close collaboration with local institutions. At the Hospital de Amor, which Lula visited, the introduction of Toumai skyrocketed the number of patients undergoing robotic surgery annually from 400 to 680. To achieve this level of safety in operations via 5G telecommunication networks, fiber optics, and satellites, Shanghai MicroPort MedBot developed a revolutionary technology featuring ultra-low latency in image transmission, multidimensional data encryption, and dynamic network optimization mechanisms. This move by Brazil to hand over the keys of its operating rooms to China confirms that the Beijing-Brasilia axis is strengthening across all levels, leaving the West to watch with bated breath.
www.bankingnews.gr
Readers’ Comments